What factors should be considered before proposing 18-F-Choline (FCH) PET/CT in rising PSA prostate cancer patients who are being considered for targeted therapy ?

M. Barbaud,I. Ferrer, V. Heury,M. Le Thiec,D. Rusu, I. Rousseau, G. Bochereau, H. Monsaint,F. Kraeber-Bodere,L. Campion,C. Rousseau

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING(2017)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要